| Biomarker ID | 1723 |
| PMID | 30672309 |
| Year | 2019 |
| Biomarker | Zn/PSA |
| Biomarker Basis | Concentration Based (ng/mL) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 480 patients were selected for the study. 361 had negative biopsies and 119 had positive biopsies |
| Senstivity | 56.3% |
| Specificity | 70.3% |
| AUC | 0.702 (95% CI: 0.659-0.742) |
| Accuracy | NA |
| Level Of Significance | p=0.0001 |
| Method Used | electrochemiluminescence immunoassay |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |